Daphne Zohar's Email & Phone Number

💼 Past Experience

Prior to PureTech Health, Daphne held a variety of executive leadership roles at companies such as Abbott Laboratories and Pepsi. She has over 20 years of experience in the technology industry, having founded and eventually leading multiple companies. Daphne’s drive to be innovative and impactful is a driving force in her work at PureTech Health. She believes that by draining the innovation from the industry, we can protect and grow our patients’ health.Daphne is an industry veteran with a wealth of experience in a variety of industries including technology, health care, and consumer goods. She is passionate about her work and continues to learn and grow in her field. She is an articulate and articulate leader, and truly understands how technology can help healthcare providers and patients operate more efficiently and effectively.

💡 Technical & Interpersonal Skills

PureTech Health is a healthcare technology company. PureTech Health's mission is to advance healthcare through innovative technology with the goal of improving patient outcomes.Zohar has been involved in the healthcare industry for over 10 years. She has a background in biotechnology, corporate finance, and strategy.Zohar is an experienced inhibitor developer and CEO.Between 2006-2011 she was the CTO of Enzyme Companies, a leading hiqh10 bioscience company. At Enzyme Companies, she led the development of a broad line of inhibitors including novel proteins and cryotoxic inhibitors.Additionally, she has spent time working at leading biotech companies such as Monsanto, Amgen, and Synbio. At Monsanto she was a Product Manager, Coordinating Biological Activities for DuPont Pioneer. At Amgen, she was a Vice President, Pfizer Business Development and Head, Regulatory Affairs. At Synbio, she was the Vice President, Corporate Development, and head of CD & DVD products.Zohar brings a wealth of experience to PureTech Health. She has a strong background in biotechnology, corporate finance, and strategy, which will help PureTech Health expand its product offering and compete against industry incumbents. Additionally, Zohar has a track record of developing broad-based inhibitors, which will increase PureTech Health's ability to protect the health of its patients.